Reported Reactions

Devices › Device types

FDA product code QCA · class 3 · Unknown

Intracranial coil-assist stent: medical device reports filed with FDA

832 reports carry this product code, 2019–2026; 3 brands with a page.

832
reports with this product code
0% of all MAUDE reports
351
reports, 12 months to August 2026
293 in the 12 months before
67.5%
classified as malfunction
62.3% across all reports
1.2%
classified as death, as reported
0.9% across all reports

Product code QCA is FDA's classification for "Intracranial coil-assist stent" (unknown panel), a class 3 device. 832 medical device reports carry this product code, 0% of the MAUDE database, from July 2019 to August 2026.

351 reports arrived in the 12 months to August 2026, up 20% from 293 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (67.5%), injury (31.3%) and death (1.2%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Neuroform Atlas 3 0mm X 21mm No Tip - Ce150930%87.9%
Neuroform Atlas 3 0mm X 15mm No Tip - Ce80411.9%90%
Fred 271135.3%10.6%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Stryker Neurovascular Cork48958.8%
Microvention33640.4%

Reports by month, five years

02142Sep 2021: 0Oct 2021: 1Nov 2021: 0Dec 2021: 02022Jan 2022: 1Feb 2022: 0Mar 2022: 0Apr 2022: 2May 2022: 4Jun 2022: 1Jul 2022: 3Aug 2022: 3Sep 2022: 1Oct 2022: 4Nov 2022: 1Dec 2022: 32023Jan 2023: 2Feb 2023: 2Mar 2023: 4Apr 2023: 2May 2023: 5Jun 2023: 7Jul 2023: 10Aug 2023: 4Sep 2023: 3Oct 2023: 6Nov 2023: 6Dec 2023: 72024Jan 2024: 10Feb 2024: 6Mar 2024: 4Apr 2024: 7May 2024: 5Jun 2024: 8Jul 2024: 15Aug 2024: 13Sep 2024: 10Oct 2024: 25Nov 2024: 22Dec 2024: 282025Jan 2025: 25Feb 2025: 16Mar 2025: 28Apr 2025: 26May 2025: 30Jun 2025: 18Jul 2025: 30Aug 2025: 35Sep 2025: 26Oct 2025: 42Nov 2025: 27Dec 2025: 202026Jan 2026: 26Feb 2026: 24Mar 2026: 33Apr 2026: 34May 2026: 30Jun 2026: 34Jul 2026: 29Aug 2026: 26

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1.2%10
Injury31.3%260
Malfunction67.5%562
Other0%0
Not given0%0

Who filed

Manufacturer report99.4%827
Voluntary report0.1%1
User facility report0%0
Distributor report0%0
Not given0.5%4

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Premature activation32839.4%
Fracturea broken bone809.6%
Retraction problem617.3%
Activation failure576.9%
Difficult or delayed activation516.1%
Activation problem253%
Migrationthe device moved from where it was placed202.4%
Breakthe device broke151.8%
Detachment of device or device componentpart of the device came off81%
Difficult to fold, unfold or collapse81%
Difficult to open or close70.8%
Device stenosis60.7%
Difficult to insertthe device was hard to insert60.7%
Entrapment of device60.7%
Material separation50.6%
Premature separation50.6%
Component missing40.5%
Difficult to advance40.5%
Difficult to removethe device was hard to remove40.5%
Structural problem40.5%

Questions about intracranial coil-assist stent reports

What is product code QCA?

FDA's classification code for "Intracranial coil-assist stent", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

832 reports through August 2026, 351 of them in the latest 12 months.

Which brands appear most often?

Neuroform Atlas 3 0mm X 21mm No Tip - Ce (150), Neuroform Atlas 3 0mm X 15mm No Tip - Ce (80) and Fred 27 (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.